Paul Tudor Jones Gilead Sciences, Inc. Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 45,200 shares of GILD stock, worth $4.06 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

45,200

Previous 521,017 91.32%

Holding current value

$4.06 Million

Previous $35.7 Million 89.4%

% of portfolio

0.01%

Previous 0.19%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $13.3 Million - $15.3 Million	210,451 Added 67.76%	521,017 $35.7 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $19.6 Million - $23.8 Million	273,136 Added 729.72%	310,566 $22.7 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $2.74 Million - $3.11 Million	37,430 New	37,430 $3.03 Million
Q2 2023 Aug 14, 2023	BUY	$76.01 - $86.7 $294,462 - $335,875	3,874 New	3,874 $298,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $7.65 Million - $8.61 Million	-132,517 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $2.88 Million - $3.6 Million	49,642 Added 59.9%	132,517 $7.88 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $5.01 Million - $5.69 Million	77,289 Added 1383.62%	82,875 $6.02 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $378,116 - $407,945	5,586 New	5,586 $390,000
Q2 2021 Aug 16, 2021	SELL	$63.47 - $69.35 $2.21 Million - $2.41 Million	-34,755 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$60.0 - $68.46 $2.09 Million - $2.38 Million	34,755 New	34,755 $2.25 Million
Q4 2020 Feb 16, 2021	SELL	$56.65 - $64.55 $1.46 Million - $1.66 Million	-25,698 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $1.6 Million - $2.01 Million	25,698 New	25,698 $1.62 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $794,148 - $922,152	-10,978 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $3.88 Million - $4.97 Million	-61,957 Reduced 84.95%	10,978 $821,000
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $1.73 Million - $1.91 Million	28,123 Added 62.76%	72,935 $4.74 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $1.94 Million - $2.14 Million	-30,969 Reduced 40.87%	44,812 $2.84 Million
Q2 2019 Aug 14, 2019	SELL	$61.87 - $69.38 $2.81 Million - $3.15 Million	-45,338 Reduced 37.43%	75,781 $5.12 Million
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $4.09 Million - $4.59 Million	65,481 Added 117.69%	121,119 $7.87 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $2.14 Million - $2.79 Million	35,364 Added 174.43%	55,638 $3.48 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $540,373 - $598,292	-7,581 Reduced 27.22%	20,274 $1.57 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $244,208 - $284,859	3,764 Added 15.62%	27,855 $1.97 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $1.47 Million - $1.79 Million	20,144 Added 510.36%	24,091 $1.82 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $280,829 - $329,653	3,947	3,947 $283,000

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account